Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,500 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 5 August 2020) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 3MB, 207 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website. 

 

 

Export 31 results:
Author Title Type [ Year(Asc)]
Filters: Author is Khunti, K.  [Clear All Filters]
2020
R. Palladino, Tabak, A. G., Khunti, K., Valabhji, J., Majeed, A., Millett, C., and Vamos, E. P., “Association between pre-diabetes and microvascular and macrovascular disease in newly diagnosed type 2 diabetes”, BMJ Open Diabetes Res Care, vol. 8, 2020.
F. Tyrer, Zaccardi, F., Khunti, K., and Morriss, R., “Incidence of Depression and First-Line Antidepressant Therapy in People with Obesity and Depression in Primary Care”, Obesity (Silver Spring), vol. 28, pp. 977-984, 2020.
H. J. L. Heerspink, Karasik, A., Thuresson, M., Melzer-Cohen, C., Chodick, G., Khunti, K., Wilding, J. P. H., Rodriguez, L. A. Garcia, Cea-Soriano, L., Kohsaka, S., Nicolucci, A., Lucisano, G., Lin, F. J., Wang, C. Y., Wittbrodt, E., Fenici, P., and Kosiborod, M., “Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort study”, Lancet Diabetes Endocrinol, vol. 8, pp. 27-35, 2020.
Y. Tang, Weiss, T., Liu, J., Rajpathak, S., and Khunti, K., “Metformin adherence and discontinuation among patients with type 2 diabetes: A retrospective cohort study”, J Clin Transl Endocrinol, vol. 20, p. 100225, 2020.
A. T. O. Nickinson, Coles, B., Zaccardi, F., Gray, L. J., Payne, T., Bown, M. J., Davies, R. S. M., Khunti, K., and Sayers, R. D., “Missed Opportunities for Timely Recognition of Chronic Limb-Threatening Ischaemia in Patients Undergoing a Major Amputation: A Population Based Cohort Study Using the UK's Clinical Practice Research Datalink”, Eur J Vasc Endovasc Surg, 2020.
F. Zaccardi, Ling, S., Lawson, C., Davies, M. J., and Khunti, K., “Severe hypoglycaemia and absolute risk of cause-specific mortality in individuals with type 2 diabetes: a UK primary care observational study”, Diabetologia, 2020.
J. S. Minhas, Coles, B., Mistri, A. K., Eveson, D. J., Hussain, S. T., Potter, J. F., Khunti, K., and Robinson, T. G., “What is the optimal blood pressure level for patients with atrial fibrillation treated with direct oral anticoagulants?”, J Hypertens, 2020.
2019
C. A. Lawson, Zaccardi, F., Squire, I., Ling, S., Davies, M. J., Lam, C. S. P., Mamas, M. A., Khunti, K., and Kadam, U. T., “20-year trends in cause-specific heart failure outcomes by sex, socioeconomic status, and place of diagnosis: a population-based study”, Lancet Public Health, vol. 4, pp. e406-e420, 2019.
F. Zaccardi, Husemoen, L. L. Nystrup, Thorsted, B. L., Webb, D. R., Paul, S. K., Davies, M. J., and Khunti, K., “Selectivity of beta-blockers, cardiovascular and all-cause mortality in people with hypoglycaemia: An observational study”, Nutr Metab Cardiovasc Dis, vol. 29, pp. 481-488, 2019.
D. Spanopoulos, Okhai, H., Zaccardi, F., Tebboth, A., Barrett, B., Busse, M., Webb, J., and Khunti, K., “Temporal variation of renal function in people with type 2 diabetes mellitus: a retrospective UK Clinical Practice Research Datalink cohort study”, Diabetes Obes Metab, 2019.
2018
K. Khunti, Danese, M. D., Kutikova, L., Catterick, D., Sorio-Vilela, F., Gleeson, M., Seshasai, S. R. Kondapa, Brownrigg, J., and Ray, K. K., “Association of a Combined Measure of Adherence and Treatment Intensity With Cardiovascular Outcomes in Patients With Atherosclerosis or Other Cardiovascular Risk Factors Treated With Statins and/or Ezetimibe”, JAMA Netw Open, vol. 1, p. e185554, 2018.
J. Wilding, Godec, T., Khunti, K., Pocock, S., Fox, R., Smeeth, L., Clauson, P., Fenici, P., Hammar, N., and Medina, J., “Changes in HbA1c and weight, and treatment persistence, over the 18 months following initiation of second-line therapy in patients with type 2 diabetes: results from the United Kingdom Clinical Practice Research Datalink”, BMC Med, vol. 16, p. 116, 2018.
M. A. Cavender, Norhammar, A., Birkeland, K. I., Jorgensen, M. E., Wilding, J. P., Khunti, K., Fu, A. Z., Bodegard, J., Blak, B. T., Wittbrodt, E., Thuresson, M., Fenici, P., Hammar, N., and Kosiborod, M., “SGLT-2 Inhibitors and Cardiovascular Risk: An Analysis of CVD-REAL”, J Am Coll Cardiol, vol. 71, pp. 2497-2506, 2018.
U. Desai, Kirson, N. Y., Kim, J., Khunti, K., King, S., Trieschman, E., Hellstern, M., Hunt, P. R., and Mukherjee, J., “Time to Treatment Intensification After Monotherapy Failure and Its Association With Subsequent Glycemic Control Among 93,515 Patients With Type 2 Diabetes”, Diabetes Care, vol. 41, pp. 2096-2104, 2018.
2017
J. P. H. Wilding, Godec, T., Khunti, K., Pocock, S., Fox, R., Smeeth, L., Clauson, P., Fenici, P., Hammar, N., and Medina, J., “Changes in HbA1c and weight after initiation of second-line therapy in patients with type 2 diabetes in clinical practice.”, Diabetologia., vol. 60, p. S301, 2017.
M. Kosiborod, Cavender, M. A., Fu, A. Z., Wilding, J. P., Khunti, K., Holl, R. W., Norhammar, A., Birkeland, K. I., Jorgensen, M. E., Thuresson, M., Arya, N., Bodegard, J., Hammar, N., and Fenici, P., “Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotranspo”, Circulation, vol. 136, pp. 249-259, 2017.
M. D. Danese, Gleeson, M., Kutikova, L., Griffiths, R. I., Khunti, K., Seshasai, S. R. K., and Ray, K. K., “Management of lipid-lowering therapy in patients with cardiovascular events in the UK: a retrospective cohort study”, BMJ Open, vol. 7, p. e013851, 2017.
2016
S. K. Paul, Klein, K., Majeed, A., and Khunti, K., “Association of smoking and concomitant metformin use with cardiovascular events and mortality in people newly diagnosed with type 2 diabetes”, J Diabetes, vol. 8, pp. 354-62, 2016.
K. Khunti, Nikolajsen, A., Thorsted, B. L., Andersen, M., Davies, M. J., and Paul, S. K., “Clinical inertia with regard to intensifying therapy in people with type 2 diabetes treated with basal insulin”, Diabetes Obes Metab, vol. 18, pp. 401-9, 2016.
M. D. Danese, Gleeson, M., Kutikova, L., Griffiths, R. I., Azough, A., Khunti, K., Seshasai, S. R., and Ray, K. K., “Estimating the economic burden of cardiovascular events in patients receiving lipid-modifying therapy in the UK”, BMJ Open, vol. 6, p. e011805, 2016.
K. C. Chang, Lee, J. T., Vamos, E. P., Soljak, M., Johnston, D., Khunti, K., Majeed, A., and Millett, C., “Impact of the National Health Service Health Check on cardiovascular disease risk: a difference-in-differences matching analysis”, Cmaj, vol. 188, pp. E228-38, 2016.
2015
S. de Lusignan, Liaw, S. T., Dedman, D., Khunti, K., Sadek, K., and Jones, S., “An algorithm to improve diagnostic accuracy in diabetes in computerised problem orientated medical records (POMR) compared with an established algorithm developed in episode orientated records (EOMR)”, J Innov Health Inform, vol. 22, pp. 255-64, 2015.
K. C. Chang, Soljak, M., Lee, J. T., Woringer, M., Johnston, D., Khunti, K., Majeed, A., and Millett, C., “Coverage of a national cardiovascular risk assessment and management programme (NHS Health Check): Retrospective database study”, Prev Med, vol. 78, pp. 1-8, 2015.
S. K. Paul, Klein, K., Thorsted, B. L., Wolden, M. L., and Khunti, K., “Delay in treatment intensification increases the risks of cardiovascular events in patients with type 2 diabetes”, Cardiovasc Diabetol, vol. 14, p. 100, 2015.
K. Khunti, Davies, M., Majeed, A., Thorsted, B. L., Wolden, M. L., and Paul, S. K., “Hypoglycemia and risk of cardiovascular disease and all-cause mortality in insulin-treated people with type 1 and type 2 diabetes: a cohort study”, Diabetes Care, vol. 38, pp. 316-22, 2015.
2014
G. Thomas, Khunti, K., Curcin, V., Molokhia, M., Millett, C., Majeed, A., and Paul, S., “Obesity paradox in people newly diagnosed with type 2 diabetes with and without prior cardiovascular disease”, Diabetes Obes Metab, vol. 16, pp. 317-25, 2014.
2013
K. Khunti, Wolden, M. L., Thorsted, B. L., Andersen, M., and Davies, M. J., “Clinical inertia in people with type 2 diabetes: a retrospective cohort study of more than 80,000 people”, Diabetes Care, vol. 36, pp. 3411-7, 2013.
2012
E. P. Vamos, Harris, M., Millett, C., Pape, U. J., Khunti, K., Curcin, V., Molokhia, M., and Majeed, A., “Association of systolic and diastolic blood pressure and all cause mortality in people with newly diagnosed type 2 diabetes: retrospective cohort study”, Bmj, vol. 345, p. e5567, 2012.
2009
I. Tzoulaki, Molokhia, M., Curcin, V., Little, M. P., Millett, C. J., Ng, A., Hughes, R. I., Khunti, K., Wilkins, M. R., Majeed, A., and Elliott, P., “Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database”, Bmj, vol. 339, p. b4731, 2009.
2005
R. Ryan, Newnham, A., Khunti, K., and Majeed, A., “New cases of diabetes mellitus in England and Wales, 1994-1998: database study”, Public Health, vol. 119, pp. 892-9, 2005.
2002
A. Newnham, Ryan, R., Khunti, K., and Majeed, A., “Prevalence of diagnosed diabetes mellitus in general practice in England and Wales, 1994 to 1998”, Health Stat Q, pp. 5-13, 2002.
[Page last reviewed 5 August 2020]